Alexion Pharmaceuticals (ALXN)
US Market

Alexion Pharmaceuticals Stock Analysis & Ratings

ALXN Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$99.91 - $187.45
Previous Close$0
Average Volume (3M)3.42M
Market CapN/A
Enterprise ValueN/A
P/E Ratio59.6
Next EarningsN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Smart Score8

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Alexion Pharmaceuticals’s price range in the past 12 months?
Alexion Pharmaceuticals lowest stock price was $99.91 and its highest was $187.45 in the past 12 months.
    What is Alexion Pharmaceuticals’s market cap?
    Currently, no data Available
    What is Alexion Pharmaceuticals’s price target?
    The average price target for Alexion Pharmaceuticals is $183.60. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
    The highest analyst price target is $205.00 ,the lowest forecast is $173.00. The average price target represents N/A Increase from the current price of N/A.
      What do analysts say about Alexion Pharmaceuticals?
      Alexion Pharmaceuticals’s analyst rating consensus is a ‘Hold. This is based on the ratings of 7 Wall Streets Analysts.
        When is Alexion Pharmaceuticals’s upcoming earnings report date?
        The company’s upcoming earnings report date is not yet available.
        How were Alexion Pharmaceuticals’s earnings last quarter?
        Currently, no data Available
        Is Alexion Pharmaceuticals overvalued?
        According to Wall Street analysts Alexion Pharmaceuticals’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Alexion Pharmaceuticals pay dividends?
          Alexion Pharmaceuticals does not currently pay dividends.
          What is Alexion Pharmaceuticals’s EPS estimate?
          Alexion Pharmaceuticals’s EPS estimate is $3.06.
            How many shares outstanding does Alexion Pharmaceuticals have?
            Alexion Pharmaceuticals has 221,020,000 shares outstanding.
              What happened to Alexion Pharmaceuticals’s price movement after its last earnings report?
              Currently, no data Available
              Which hedge fund is a major shareholder of Alexion Pharmaceuticals?
              Among the largest hedge funds holding Alexion Pharmaceuticals’s share is Paulson & Co Inc. It holds Alexion Pharmaceuticals’s shares valued at 214M.


                Alexion Pharmaceuticals Stock Analysis

                Smart Score
                Price TargetHold
                The Alexion Pharmaceuticals stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description

                Alexion Pharmaceuticals

                Alexion Pharmaceuticals, Inc. is a biopharmaceutical company. The firm focuses on developing life-transforming drugs that are used for treating patients with ultra-rare diseases and disorders.

                Similar Stocks
                Price & Change
                Alnylam Pharma
                Sarepta Therapeutics
                Agios Pharma

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis